Published Date: 28 Oct 2023
In Indiana, the expenses associated with untreated mental illness in 2019 amounted to over $4 billion, comprising direct healthcare, non-healthcare, and indirect costs. This amounts to 1.2 percent of the state's GDP.
Read Full NewsNot all adrenal incidentalomas need the same workup. The Curbsiders break down when to worry, what to test, and why MACS may be behind your patient's hard-to-control metabolic disease.
Dr Maurie Markman examines new registry data on ovarian cancer diagnostic timing, showing how disease biology can complicate the link between early detection and survival.
Dr Andrea Chadwick describes how the shift from tender points to symptom-based criteria has improved fibromyalgia diagnosis, understanding, and patient-centered care.
Dr Anne Peters discusses the expanding use of continuous glucose monitoring in people with diabetes.
Before you freeze a skin lesion, ask yourself whether you really know what it is. Here are four signs you should biopsy instead of freeze.
EyePoint said its experimental drug missed the main goal in a late-stage trial as a few patients lost vision from causes unrelated to the targeted disease, sending its...
The FDA has approved a radioactive agent for use in brain scans to help assess patients for Alzheimer's disease.
1.
Breast cancer patients' arms swell less after an effective lymph node transfer.
2.
Browse the NBE-Released Curriculum at FNB Head and Neck Oncology.
3.
Brexpiprazole Safe, Effective in Early-Episode Schizophrenia
4.
Which women need more than mammograms for breast cancer screening?
5.
Cancer screening rates down among American adults
1.
Case-Based Learning on Clonal Hematopoiesis With Unexpected Clinical Progression
2.
Tumor Ecosystem Rewiring Through Adaptive Therapeutics
3.
Understanding Macrocytosis: Causes, Symptoms, and Treatment Options
4.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
5.
Evolutionary Intelligence for Oncology Research Optimization
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
2.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
3.
Navigating the Complexities of Ph Negative ALL - Part XVI
4.
Signs and Symptoms of Leukemia
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation